This information is only for reference, not for medical use

Print This Page
  • B.C.G.
  • Polio ( Polio) – zero polio
  • Hepatitis B – first
 
1.5 months
  • D.P.T. – 1st dose
  • Polio ( 1st dose
  • Hepatitis–B– 2nd
  • HIB Meningitis – Brain Fever – 1st  dose
2.5 months
  • DPT – 2nd  dose
  • Polio -  2nddose
  • HIB Meningitis – 2nd dose
 3.5 months
  • DPT – 3rd dose
  • Polio – 3rd  dose
  • HIB Meningitis – 3rd  dose
6 months
  • Hepatitis-B – 3rd dose
9 months
  • Measles
  • Polio – 5th dose
15 months
  • M M R
1 year
  • Chickenpox
1.5 years
  • DPT Booster
  • Polio – Booster
  • HIB Meningitis – Booster dose
2 years
  • Typhoid
  • Hepatitis A
Vaccine Manufacturer BLA submitted to FDA BLA age indications** FDA licensure
DTaP/IPV (KINRIX) GlaxoSmithKline (GSK) Jun-2007 4 through 6 years of age Licensed 24-Jun-08
Hib/DTaP/IPV (PENTACEL™) sanofi pasteur Jul-2005 2, 4, 6, and 15 to 18 months of age Licensed 20-Jun-08
Hib(Hiberix) GlaxoSmithKline (GSK) Mar-2009 Booster dose in children 15 months through 4 years of age Licensed 19-Aug-09
Hepatitis A (VAQTA®) Merck Supplement to original BLA Greater than or equal to 12 months of age Licensed 11-Aug-05
Hepatitis A (HAVRIX®) GlaxoSmithKline (GSK) Supplement to original BLA Greater than or equal to 12 months of age Licensed 17-Oct-05
Hepatitis A and Hepatitis B (TWINRIX®) GlaxoSmithKline (GSK) Supplement to original BLA: accelerated dosing Greater than or equal to 18 years of age
0, 7, and 21 through 30 days and 12 month booster
Licensed 28-Mar-07
Herpes zoster vaccine (ZOSTAVAX®) Merck Apr-2005 Greater than or equal to 60 years of age Licensed 25-May-06
HPV (GARDASIL®) Merck Dec-2005 9 through 26 years of age (3 doses) Licensed 8-Jun-06
Supplement to original BLA 27 through 45 years of age To be reviewed
HPV (Cervarix™) GlaxoSmithKline (GSK) Mar-2007 Data not available To be reviewed
Influenza vaccines - TIV varies n/a See recommendations varies
Influenza - LAIV-T (FluMist®) MedImmune Supplement to original BLA 24 months to 49 years of age Licensed 19-Sep-07
Japanese Encephalitis (IXIARO) Intercell Biomedical Dec-2007 Greater than or equal to 17 years of age Licensed 30-Mar-09
MCV4 (Menactra®) sanofi pasteur Dec-2003 11 through 55 years of age Licensed 14-Jan-05
Supplement to original BLA March 2005 2 through 10 years of age only for children at high risk Licensed 18-Oct-07
MCV4 (Menveo™) Novartis Aug-2008 11 through 55 years of age To be reviewed
MMRV (ProQuad®) Merck Aug-2004 Same as for MMR dose 1 or dose 2; 12 months to 12 years of age Licensed 6-Sep-05
PCV13 (Prevnar 13®) Wyeth Mar-2009 2 months to 5 years of age To be reviewed
Rotavirus (ROTATEQ®) Merck Apr-2005 2, 4, and 6 months of age Licensed 3-Feb-06
Rotavirus (ROTARIX®) GlaxoSmithKline (GSK) Jun-2007 2 and 4 months of age Licensed 3-Apr-08
Tdap (BOOSTRIX®) GlaxoSmithKline (GSK) Jul-2004 10 through 18 years of age Licensed 3-May-05
Supplement to original BLA 19 through 64 years of age Licensed 4-Dec-08
Tdap (ADACEL™) sanofi pasteur Aug-2004 11 through 64 years of age Licensed 10-Jun-05
Varicella virus second dose (Varivax®) Merck Supplement to original BLA: second dose 12 months to 12 years of age (3 month minimum interval) Licensed 5-Apr-05

This information is only for reference, not for medical use